FDA.reportPublic FDA data

SODIUM FORMALDEHYDE SULFOXYLATE

Substance profile for UNII X4ZGP7K714, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM FORMALDEHYDE SULFOXYLATE
Structure render from PubChem CID 23689980

Substance Identity#

UNII
X4ZGP7K714
Preferred term
SODIUM FORMALDEHYDE SULFOXYLATE
Registry number
149-44-0
EC number
205-739-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
CH3O3S.Na
Chemical structure for SODIUM FORMALDEHYDE SULFOXYLATE
Structure render from PubChem CID 23689980

Chemical And Database Identifiers#

InChIKey
XWGJFPHUCFXLBL-UHFFFAOYSA-M
SMILES
[Na+].OCS([O-])=O
RxCUI
0
PubChem
23689980
NCIt
C76732
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23689980pubchem.ncbi.nlm.nih.gov/compound/23689980
PubChem InChIKey SearchXWGJFPHUCFXLBL-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=XWGJFPHUCFXLBL-UHFFFAOYSA-M
NCI ThesaurusC76732ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76732
FDA Substance Registration SystemX4ZGP7K714precision.fda.gov/uniisearch/srs/unii/X4ZGP7K714
European Community number205-739-4commonchemistry.cas.org/results?q=205-739-4

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
Hexasol TM Injection (oxytetracycline and flunixin meglumine)1
RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC]9
RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]6
RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HERITAGE PHARMACEUTICALS INC.]5
BANAMINE (FLUNIXIN MEGLUMINE) INJECTION [SCHERING CORPORATION]3
RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]3
300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]2
FLUNIXIN-S (FLUNIXIN MEGLUMINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]2
MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.]2
NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED]2
BACTRACILLIN G (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [ASPEN VETERINARY]1
BIO-MYCIN 200 (OXYTETRACYCLINE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]1
LIQUAMYCIN LA-200 (OXYTETRACYCLINE) INJECTION, SOLUTION [ZOETIS INC.]1
NOROMYCIN 300 LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]1
OXYTETRACYCLINE INJECTION 200 (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]1
RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]1
RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1
SULFAMED (SULFADIMETHOXINE) INJECTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII X4ZGP7K714 page 1 of 1 ยท 5 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM FORMALDEHYDE SULFOXYLATEX4ZGP7K71416750315INJECTIONINTRAMUSCULAR3 mg
SODIUM FORMALDEHYDE SULFOXYLATEX4ZGP7K71416750315INJECTIONINTRAVENOUS3 mg
SODIUM FORMALDEHYDE SULFOXYLATEX4ZGP7K71416750315INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS11 mg
SODIUM FORMALDEHYDE SULFOXYLATEX4ZGP7K71416750315INJECTIONSUBCUTANEOUS3 mg
SODIUM FORMALDEHYDE SULFOXYLATEX4ZGP7K71416750315CREAMTOPICALNA